<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/getting-foundation-right-sam-hinsley-phastar</loc><lastmod>2026-06-03T13:39:00Z</lastmod><news:news><news:publication_date>2026-06-03T13:39:00Z</news:publication_date>
        <news:title><![CDATA[Getting the Foundation Right: Q&A with Sam Hinsley, Phastar]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/scope-copd-case-study-ai-enrollment</loc><lastmod>2026-06-03T11:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T11:00:00Z</news:publication_date>
        <news:title><![CDATA[SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/ai-driven-patient-matching-clinical-ops-tensions-oral-covid-prevention-approval</loc><lastmod>2026-06-03T10:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: AI-Driven Patient Matching, Clinical Ops Tensions, and Oral COVID Prevention Approval]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/scope-real-time-patient-data-clinops-efficiency</loc><lastmod>2026-06-02T19:15:00Z</lastmod><news:news><news:publication_date>2026-06-02T19:15:00Z</news:publication_date>
        <news:title><![CDATA[SCOPE X: What Real-Time Patient Data Is Doing to ClinOps Efficiency ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/three-tensions-transforming-clinical-operations-excellence</loc><lastmod>2026-06-02T14:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Three Tensions Transforming Clinical Operations Excellence]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/process-architecture-autonomous-ai-real-time-rwe-integration-rwe-infrastructure</loc><lastmod>2026-06-02T10:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Process Architecture Over Autonomous AI, Real-Time RWE Integration, and Building RWE Infrastructure]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/real-world-evidence-clinical-trials-industry</loc><lastmod>2026-06-01T15:53:00Z</lastmod><news:news><news:publication_date>2026-06-01T15:53:00Z</news:publication_date>
        <news:title><![CDATA[Real-World Evidence in Clinical Trials: Where the Industry Stands and Where It's Headed]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/real-world-evidence-approval</loc><lastmod>2026-06-01T12:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Why Real-World Evidence Can No Longer Wait Until After Approval]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/scope-industry-ai-architecture-clinical-trials</loc><lastmod>2026-06-01T11:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T11:00:00Z</news:publication_date>
        <news:title><![CDATA[SCOPE X: What the Industry Needs to Understand About AI Architecture in Clinical Trials ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/ai-decision-making-community-trust-trial-engagement-lupus-treatment</loc><lastmod>2026-06-01T10:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: AI Freeing Experts for Decision Making, Community Trust in Trial Engagement, and Lupus Treatment Breakthroughs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/beyond-recruitment-del-smith-acclinate</loc><lastmod>2026-05-29T13:23:00Z</lastmod><news:news><news:publication_date>2026-05-29T13:23:00Z</news:publication_date>
        <news:title><![CDATA[Beyond Recruitment: Q&A with Del Smith, PhD, Acclinate]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/scope-infrastructure-human-experts-decisions</loc><lastmod>2026-05-29T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T11:00:00Z</news:publication_date>
        <news:title><![CDATA[SCOPE X: How the Right Infrastructure Frees Human Experts to Actually Make Decisions ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/data-capture-execution-coordinator-performance-covid-vaccine-vote</loc><lastmod>2026-05-29T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Data Capture vs. Execution, Coordinator Performance Gaps, and COVID Vaccine Composition Vote]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/objective-study-clinical-research-coordinator-work-quality</loc><lastmod>2026-05-28T19:23:00Z</lastmod><news:news><news:publication_date>2026-05-28T19:23:00Z</news:publication_date>
        <news:title><![CDATA[An Objective Study of Clinical Research Coordinator Work Quality]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/scope-clinical-trials-operational-conductor</loc><lastmod>2026-05-28T18:50:00Z</lastmod><news:news><news:publication_date>2026-05-28T18:50:00Z</news:publication_date>
        <news:title><![CDATA[SCOPE X: Why Clinical Trials Still Need an Operational Conductor ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/ecoa-costs-paper-persistence-early-phase-statistical-foundations-dei-progress-trials</loc><lastmod>2026-05-28T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: eCOA Costs and Paper Persistence, Early Phase Statistical Foundations, and DEI Progress in Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/ai-in-biotech-clinical-development-why-you-can-t-afford-to-retrofit</loc><lastmod>2026-05-28T04:30:00Z</lastmod><news:news><news:publication_date>2026-05-28T04:30:00Z</news:publication_date>
        <news:title><![CDATA[AI in Biotech Clinical Development: Why You Can't Afford to Retrofit]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/ecoa-uat-validating-complex-time-dependent-workflows</loc><lastmod>2026-05-28T04:30:00Z</lastmod><news:news><news:publication_date>2026-05-28T04:30:00Z</news:publication_date>
        <news:title><![CDATA[eCOA UAT: Validating Complex Time-Dependent Workflows]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/gameto-accelerating-global-clinical-studies-in-3-weeks</loc><lastmod>2026-05-28T04:30:00Z</lastmod><news:news><news:publication_date>2026-05-28T04:30:00Z</news:publication_date>
        <news:title><![CDATA[Gameto: Accelerating Global Clinical Studies in 3 Weeks]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/the-ecoa-iceberg-uncovering-the-hidden-costs-of-software-only-models</loc><lastmod>2026-05-28T04:30:00Z</lastmod><news:news><news:publication_date>2026-05-28T04:30:00Z</news:publication_date>
        <news:title><![CDATA[The eCOA Iceberg: Uncovering the Hidden Costs of Software-Only Models]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/current-state-dei-clinical-trials-progress-pressure-path-forward</loc><lastmod>2026-05-27T18:58:00Z</lastmod><news:news><news:publication_date>2026-05-27T18:58:00Z</news:publication_date>
        <news:title><![CDATA[The Current State of DEI in Clinical Trials: Progress, Pressure, and the Path Forward]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/paper-clinical-outcome-assessment-data-collection</loc><lastmod>2026-05-27T13:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T13:00:00Z</news:publication_date>
        <news:title><![CDATA[When Does Paper Make Sense for Clinical Outcome Assessment Data Collection?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/early-phase-trials-consequential</loc><lastmod>2026-05-27T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Why Getting Early Phase Trials Right Is So Consequential ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/diversity-statistician-collaboration-hdv-treatment</loc><lastmod>2026-05-27T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Diversity Embedded as Standard Practice, Early Phase Statistician Collaboration, and First HDV Treatment Approved]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/building-trust-enrollment-adrelia-allen-merck</loc><lastmod>2026-05-26T13:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Building Trust, Not Just Enrollment: Q&A with Adrelia Allen, Merck]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/early-phase-esig-accomplish</loc><lastmod>2026-05-26T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Inside the Early Phase ESIG and What It Aims to Accomplish ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/cnpv-statistician-collaboration-complex-trials-glp-1-market</loc><lastmod>2026-05-26T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: CNPV Program Operational Realities, Statistician Collaboration in Complex Trials, and GLP-1 Market Concentration]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/accelerating-patient-recruitment-connecting-the-right-patients-to-the-right-trial-1</loc><lastmod>2026-05-22T16:48:00Z</lastmod><news:news><news:publication_date>2026-05-22T16:48:00Z</news:publication_date>
        <news:title><![CDATA[Accelerating patient recruitment: Connecting the right patients to the right trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/6-ways-lab-data-can-improve-clinical-trials</loc><lastmod>2026-05-22T16:47:00Z</lastmod><news:news><news:publication_date>2026-05-22T16:47:00Z</news:publication_date>
        <news:title><![CDATA[6 Ways Lab Data Can Improve Clinical Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/5-essential-capabilities-for-decentralized-clinical-trials</loc><lastmod>2026-05-22T16:46:00Z</lastmod><news:news><news:publication_date>2026-05-22T16:46:00Z</news:publication_date>
        <news:title><![CDATA[5 Essential Capabilities for Decentralized Clinical Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/revitalizing-recruitment-in-a-lupus-rescue-study-a-collaborative-approach-by-quest-diagnostics-and-patientslikeme</loc><lastmod>2026-05-22T16:45:00Z</lastmod><news:news><news:publication_date>2026-05-22T16:45:00Z</news:publication_date>
        <news:title><![CDATA[Revitalizing recruitment in a lupus rescue study: A collaborative approach by Quest Diagnostics and PatientsLikeMe]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/fda-commissioner-national-priority-voucher-program-promise-pressure-operational-reality</loc><lastmod>2026-05-22T13:37:00Z</lastmod><news:news><news:publication_date>2026-05-22T13:37:00Z</news:publication_date>
        <news:title><![CDATA[Inside the FDA's Commissioner's National Priority Voucher Program: Promise, Pressure, and Operational Reality]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/cross-stakeholder-collaboration-essential-clinical-trial-innovation</loc><lastmod>2026-05-22T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Why Cross-Stakeholder Collaboration Is Essential to Clinical Trial Innovation ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/rbqm-ai-integration-statistician-data-oncology-regulatory</loc><lastmod>2026-05-22T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: RBQM and AI Integration, Statistician Role in Data Stewardship, and Oncology Regulatory Navigation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/ai-advanced-statistics-research</loc><lastmod>2026-05-21T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T12:00:00Z</news:publication_date>
        <news:title><![CDATA[How AI and Advanced Statistics Are Helping Research Rise]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/statisticians-clinical-development</loc><lastmod>2026-05-21T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T11:00:00Z</news:publication_date>
        <news:title><![CDATA[How Statisticians Can Help Raise Standards Across Clinical Development ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/clinical-development-career-insights-trials-fda-communication</loc><lastmod>2026-05-21T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Clinical Development Orchestration, Career Insights in Trials, and FDA Communication Gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/the-expanding-role-of-u-hplc-and-lc-ms-in-next-generation-biopharmaceuticals</loc><lastmod>2026-05-21T04:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T04:00:00Z</news:publication_date>
        <news:title><![CDATA[The Expanding Role of (U)HPLC and LC-MS in Next-Generation Biopharmaceuticals]]></news:title>
        <news:keywords><![CDATA[webcasts]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/clinical-trials-day-changing-equation-rd-success</loc><lastmod>2026-05-20T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Clinical Trials Day and the Changing Equation of R&D Success]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/clinical-trials-day-mean-you</loc><lastmod>2026-05-20T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T11:00:00Z</news:publication_date>
        <news:title><![CDATA[What Does Clinical Trials Day Mean to You?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/safety-monitoring-alignment-ai-performance-emerging-real-time-data-quality-challenges</loc><lastmod>2026-05-20T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Safety Monitoring Alignment, AI Performance Gap Emerging, and Real-Time Data Quality Challenges]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/medidata-report-ai-adopters-clinical-trial-timelines</loc><lastmod>2026-05-19T18:39:00Z</lastmod><news:news><news:publication_date>2026-05-19T18:39:00Z</news:publication_date>
        <news:title><![CDATA[Medidata Report Finds Early AI Adopters Pulling Ahead on Clinical Trial Timelines]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/safety-reporting-rbqm-risk-assessment-monitoring</loc><lastmod>2026-05-19T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-19T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Safety Reporting in RBQM: Bridging Risk Assessment, Monitoring, and Action]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/trial-representation-design-cro-revenue-fda-data-review</loc><lastmod>2026-05-19T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-19T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Trial Representation and Design, CRO Revenue Recognition Risks, and Real-Time FDA Data Review]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/revenue-recognition-risk-in-contract-research-organizations</loc><lastmod>2026-05-18T13:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Revenue Recognition Risk in Contract Research Organizations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/operational-realities-building-representative-clinical-trials</loc><lastmod>2026-05-18T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T11:00:00Z</news:publication_date>
        <news:title><![CDATA[The Operational Realities of Building More Representative Clinical Trials ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/trust-clinical-trial-engagement-participant-readiness-adherence-ai-regulatory-compliance</loc><lastmod>2026-05-18T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-18T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Trust in Clinical Trial Engagement, Participant Readiness and Adherence, and AI in Regulatory Compliance]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/apps-exposure-participant-adherence-readiness</loc><lastmod>2026-05-15T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Beyond Apps and Exposure: Why Participant Adherence Begins With Readiness]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/lets-talk-trials-access-trust-gap</loc><lastmod>2026-05-15T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T11:00:00Z</news:publication_date>
        <news:title><![CDATA[What Let's Talk Trials Is Doing to Close the Access and Trust Gap ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/diversity-trial-design-unified-patient-outcome-data-ai-protocol-development</loc><lastmod>2026-05-15T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-15T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Diversity Embedded in Trial Design, Unified Patient Outcome Data, and AI-Informed Protocol Development]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/merck-representation-clinical-trial-execution</loc><lastmod>2026-05-14T15:09:00Z</lastmod><news:news><news:publication_date>2026-05-14T15:09:00Z</news:publication_date>
        <news:title><![CDATA[How Merck Is Embedding Representation Into Clinical Trial Execution ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/signant-health-acquires-ametris-integrated-ecoa-digital-outcome-measures-platform</loc><lastmod>2026-05-14T13:09:00Z</lastmod><news:news><news:publication_date>2026-05-14T13:09:00Z</news:publication_date>
        <news:title><![CDATA[Signant Health Acquires Ametris to Build Integrated eCOA and Digital Outcome Measures Platform]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/makary-fda-tenure-pediatric-trial-experience-design-weight-loss-maintenance-data</loc><lastmod>2026-05-14T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-14T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Makary's Turbulent FDA Tenure, Pediatric Trial Experience Design, and Weight Loss Maintenance Data]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/operationalizing-qualified-e-signatures-in-e-consent-a-practical-playbook-for-global-trials</loc><lastmod>2026-05-14T04:00:00Z</lastmod><news:news><news:publication_date>2026-05-14T04:00:00Z</news:publication_date>
        <news:title><![CDATA[Operationalizing Qualified e-Signatures in e-Consent: A Practical Playbook for Global Trials]]></news:title>
        <news:keywords><![CDATA[webcasts]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/balancing-scientific-innovation-lived-experience-strategic-imperative-pediatric-clinical-trials</loc><lastmod>2026-05-13T19:33:00Z</lastmod><news:news><news:publication_date>2026-05-13T19:33:00Z</news:publication_date>
        <news:title><![CDATA[Balancing Scientific Innovation with Lived Experience: A Strategic Imperative in Pediatric Clinical Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/fda-commissioner-makary-tumultuous-tenure-agency-transition</loc><lastmod>2026-05-13T14:44:00Z</lastmod><news:news><news:publication_date>2026-05-13T14:44:00Z</news:publication_date>
        <news:title><![CDATA[End of FDA Commissioner Makary’s Tumultuous Tenure Leaves Agency in Transition]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/cloud-native-imaging-infrastructure-community-relationships-trial-design-fda-leadership-transition</loc><lastmod>2026-05-13T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-13T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Cloud-Native Imaging Infrastructure, Community Relationships in Trial Design, and FDA Leadership Transition]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/evidence-based-roi-analysis-cloud-native-traditional-imaging-infrastructure-clinical-trials</loc><lastmod>2026-05-12T18:16:00Z</lastmod><news:news><news:publication_date>2026-05-12T18:16:00Z</news:publication_date>
        <news:title><![CDATA[Beyond the Hype: An Evidence-Based ROI Analysis of Cloud-Native vs. Traditional Imaging Infrastructure in Clinical Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/community-engagement-long-term-value-enrollment</loc><lastmod>2026-05-12T16:05:00Z</lastmod><news:news><news:publication_date>2026-05-12T16:05:00Z</news:publication_date>
        <news:title><![CDATA[How Community Engagement Creates Long-Term Value Beyond Enrollment ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/protocol-design-business-strategy-site-financial-pressures-fda-leadership-uncertainty</loc><lastmod>2026-05-12T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-12T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: Protocol Design as Business Strategy, Site Financial Pressures, and FDA Leadership Uncertainty]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/2026-2027-top-10-heor-trends</loc><lastmod>2026-05-12T04:30:00Z</lastmod><news:news><news:publication_date>2026-05-12T04:30:00Z</news:publication_date>
        <news:title><![CDATA[2026-2027 Top 10 HEOR Trends]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/clinical-research-sites-operate-compete-deliver</loc><lastmod>2026-05-11T18:21:00Z</lastmod><news:news><news:publication_date>2026-05-11T18:21:00Z</news:publication_date>
        <news:title><![CDATA[Sites Under Pressure: What Clinical Research Sites Need to Operate, Compete, and Deliver]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/protocol-design-business-strategy-mark-freitas-alvarez-marsal</loc><lastmod>2026-05-11T16:21:00Z</lastmod><news:news><news:publication_date>2026-05-11T16:21:00Z</news:publication_date>
        <news:title><![CDATA[Protocol Design as Business Strategy: Q&A with Mark Freitas, Alvarez & Marsal]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/esource-data-integration-patient-site-performance-pragmatic-trial-safety-framework</loc><lastmod>2026-05-11T10:00:00Z</lastmod><news:news><news:publication_date>2026-05-11T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: eSource Data Integration, Direct-to-Patient Site Performance, and Pragmatic Trial Safety Framework]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/transcelerate-fda-streamlined-safety-data-collection-pragmatic-clinical-trials</loc><lastmod>2026-05-08T19:53:00Z</lastmod><news:news><news:publication_date>2026-05-08T19:53:00Z</news:publication_date>
        <news:title><![CDATA[TransCelerate and FDA Advance Work on Streamlined Safety Data Collection for Pragmatic Clinical Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/direct-to-patient-clinical-trial-site-access-patient-representation</loc><lastmod>2026-05-08T18:40:36.135Z</lastmod><news:news><news:publication_date>2026-05-08T18:40:36.135Z</news:publication_date>
        <news:title><![CDATA[Evaluating the Impact of a Direct-to-Patient Clinical Trial Site on Performance, Access, and Patient Representation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/crio-medidata-partnership-clinical-trial-data-friction</loc><lastmod>2026-05-08T15:18:00Z</lastmod><news:news><news:publication_date>2026-05-08T15:18:00Z</news:publication_date>
        <news:title><![CDATA[CRIO and Medidata Partnership Targets Clinical Trial Data Friction]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/crossing-the-digital-chasm-site-burden-isn-t-an-excuse-anymore</loc><lastmod>2026-05-08T14:51:52.803Z</lastmod><news:news><news:publication_date>2026-05-08T14:51:52.803Z</news:publication_date>
        <news:title><![CDATA[Crossing the Digital Chasm: Site Burden Isn’t an Excuse Anymore ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/how-quest-diagnostics-is-revolutionizing-patient-recruitment-with-data-and-precision</loc><lastmod>2026-05-08T04:00:00Z</lastmod><news:news><news:publication_date>2026-05-08T04:00:00Z</news:publication_date>
        <news:title><![CDATA[ How Quest Diagnostics Is Revolutionizing Patient Recruitment With Data and Precision]]></news:title>
        <news:keywords><![CDATA[webcasts]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/moderna-mrna-1010-influenza-vaccine-</loc><lastmod>2026-05-07T18:59:47.792Z</lastmod><news:news><news:publication_date>2026-05-07T18:59:47.792Z</news:publication_date>
        <news:title><![CDATA[Phase 3 Trial Finds Moderna’s mRNA-1010 Influenza Vaccine Outperformed Standard-Dose Vaccines in Adults Aged 50 Years and Older]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/incyte-announces-week-24-results-true-ad4-phase-iii-trial-opzelura</loc><lastmod>2026-05-07T14:12:25.678Z</lastmod><news:news><news:publication_date>2026-05-07T14:12:25.678Z</news:publication_date>
        <news:title><![CDATA[Incyte Announces Week 24 Results from TRuE-AD4 Phase III Trial of Opzelura]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/mirikizumab-trial-disease-clearance-ulcerative-colitis</loc><lastmod>2026-05-07T13:10:55.422Z</lastmod><news:news><news:publication_date>2026-05-07T13:10:55.422Z</news:publication_date>
        <news:title><![CDATA[Mirikizumab Trial Extension Data Show 4-Year Disease Clearance in Some Adults With Ulcerative Colitis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/guselkumab-phase-3-fistula-remission-perianal-crohn-disease</loc><lastmod>2026-05-06T15:06:05.319Z</lastmod><news:news><news:publication_date>2026-05-06T15:06:05.319Z</news:publication_date>
        <news:title><![CDATA[Guselkumab Phase 3 Data Show Higher Fistula Remission in Perianal Crohn Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/first-patient-dosed-azenosertib-aspenova-phase-iii-trial-ovarian-cancer</loc><lastmod>2026-05-06T13:35:04.764Z</lastmod><news:news><news:publication_date>2026-05-06T13:35:04.764Z</news:publication_date>
        <news:title><![CDATA[First Patient Dosed with Azenosertib in Aspenova Phase III Trial for Treatment of Ovarian Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/clinical-trial-commercial-strategy-study-data-product-lifecycle</loc><lastmod>2026-05-05T19:39:39.843Z</lastmod><news:news><news:publication_date>2026-05-05T19:39:39.843Z</news:publication_date>
        <news:title><![CDATA[Translating Clinical Trial Insights into Commercial Strategy: Leveraging Study Data Across the Product Lifecycle]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/fda-clears-investigational-new-drug-application-phase-ib-iia-trial-ck0802-steroid-refractory-graft-versus-host-disease</loc><lastmod>2026-05-05T14:27:18.544Z</lastmod><news:news><news:publication_date>2026-05-05T14:27:18.544Z</news:publication_date>
        <news:title><![CDATA[FDA Clears Investigational New Drug Application for Phase Ib/IIa Trial of CK0802 in Steroid-Refractory Graft-Versus-Host Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/resilient-clinical-supply-chain</loc><lastmod>2026-05-05T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-05T11:00:00Z</news:publication_date>
        <news:title><![CDATA[What a Truly Resilient Clinical Supply Chain Actually Looks Like ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/late-execution-strategy-sponsors-</loc><lastmod>2026-05-04T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-04T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Hidden Cost of Late Execution Strategy: Why Most Sponsors Are Solving the Wrong Problem at the Wrong Time]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/geopolitical-disruption-clinical-supply-chain-planning</loc><lastmod>2026-05-04T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-04T11:00:00Z</news:publication_date>
        <news:title><![CDATA[How Geopolitical Disruption Is Changing Clinical Supply Chain Planning ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/ecoa-data-best-practices-clinical-trial-lifecycle</loc><lastmod>2026-05-01T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-01T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Managing eCOA Data: Best Practices Across the Clinical Trial Lifecycle]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/labeling-errors-propagate-patient-safety</loc><lastmod>2026-05-01T11:00:00Z</lastmod><news:news><news:publication_date>2026-05-01T11:00:00Z</news:publication_date>
        <news:title><![CDATA[How Labeling Errors Propagate and What That Means for Patient Safety ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/data-ecosystems-research-drug-safety-pregnancy</loc><lastmod>2026-04-30T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[How Modern Data Ecosystems are Transforming Research for Drug Safety in Pregnancy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/disconnected-systems-fail-sponsors-cmo</loc><lastmod>2026-04-30T11:00:00Z</lastmod><news:news><news:publication_date>2026-04-30T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Where Disconnected Systems Fail Sponsors and CMOs Most ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/fda-real-time-clinical-trials</loc><lastmod>2026-04-29T17:20:00Z</lastmod><news:news><news:publication_date>2026-04-29T17:20:00Z</news:publication_date>
        <news:title><![CDATA[FDA Launches Proof-of-Concept Real-Time Clinical Trials]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/elranatamab-survival-relapsed-refractory-multiple-myeloma</loc><lastmod>2026-04-29T14:25:57.190Z</lastmod><news:news><news:publication_date>2026-04-29T14:25:57.190Z</news:publication_date>
        <news:title><![CDATA[Elranatamab Improves Survival in Phase 3 Trial for Relapsed/Refractory Multiple Myeloma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/clinical-supply-chain-fragmentation-resilience-problem</loc><lastmod>2026-04-29T11:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Why Clinical Supply Chain Fragmentation Is Now a Resilience Problem ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/ai-governance-site-payment-experience-schizophrenia-relapse-prevention</loc><lastmod>2026-04-29T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-29T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: AI Governance Lag, Site Payment Experience, and Schizophrenia Relapse Prevention]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/sites-payment-experience-competitive-advantage</loc><lastmod>2026-04-28T12:00:00Z</lastmod><news:news><news:publication_date>2026-04-28T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Sites Are Walking Away: Why Payment Experience is the New Competitive Advantage ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/execution-breaks-down-governance-ai</loc><lastmod>2026-04-28T11:00:00Z</lastmod><news:news><news:publication_date>2026-04-28T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Where Execution Breaks Down When Governance Can't Keep Up with AI ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/ai-impact-supply-chain-risks-rwe-global-strategy</loc><lastmod>2026-04-28T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-28T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: AI Impact Faces Reality Check, Supply Chain Risks Intensify, and RWE Shapes Global Strategy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/complexity-mastered-a-blueprint-for-delivering-simultaneous-trials-at-scale</loc><lastmod>2026-04-28T04:30:00Z</lastmod><news:news><news:publication_date>2026-04-28T04:30:00Z</news:publication_date>
        <news:title><![CDATA[Complexity mastered: A blueprint for delivering simultaneous trials at scale]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/disruption-default-clinical-trial-supply-chain-hal-green-loftware</loc><lastmod>2026-04-27T18:32:00Z</lastmod><news:news><news:publication_date>2026-04-27T18:32:00Z</news:publication_date>
        <news:title><![CDATA[When Disruption Becomes the Default in the Clinical Trial Supply Chain: Q&A with Hal Green, Loftware]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/promise-reality-ai-protocol-development</loc><lastmod>2026-04-27T11:00:00Z</lastmod><news:news><news:publication_date>2026-04-27T11:00:00Z</news:publication_date>
        <news:title><![CDATA[The Promise and Reality of AI in Protocol Development ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/cro-regulatory-reimbursement-site-selection</loc><lastmod>2026-04-27T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-27T10:00:00Z</news:publication_date>
        <news:title><![CDATA[ACT Brief: CRO Consolidation in Regulatory Services, Reimbursement in Development Planning, and Site Selection Misalignment]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/veristat-acquire-certara-regulatory-medical-writing-business-expansion-cro-capabilities</loc><lastmod>2026-04-24T15:44:00Z</lastmod><news:news><news:publication_date>2026-04-24T15:44:00Z</news:publication_date>
        <news:title><![CDATA[Veristat to Acquire Certara's Regulatory and Medical Writing Business in Expansion of CRO Capabilities]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/reimbursement-trial-design-start</loc><lastmod>2026-04-24T11:00:00Z</lastmod><news:news><news:publication_date>2026-04-24T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Why Reimbursement Needs to Be Part of Trial Design from the Start ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/feasibility-gap-strong-sites-study-opportunities</loc><lastmod>2026-04-24T10:00:00Z</lastmod><news:news><news:publication_date>2026-04-24T10:00:00Z</news:publication_date>
        <news:title><![CDATA[The Feasibility Gap: Why Strong Sites Miss Study Opportunities]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/fda-lunsotogene-parvec-otof-related-genetic-hearing-loss</loc><lastmod>2026-04-23T18:13:42.206Z</lastmod><news:news><news:publication_date>2026-04-23T18:13:42.206Z</news:publication_date>
        <news:title><![CDATA[FDA Clears Lunsotogene Parvec for OTOF-Related Genetic Hearing Loss]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/oral-semaglutide-hba1c-youth-type-2-diabetes</loc><lastmod>2026-04-23T13:58:18.775Z</lastmod><news:news><news:publication_date>2026-04-23T13:58:18.775Z</news:publication_date>
        <news:title><![CDATA[Oral Semaglutide Lowers HbA1c in Phase 3 Trial in Youth With Type 2 Diabetes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.appliedclinicaltrialsonline.com/view/trial-design-obesity-oncology</loc><lastmod>2026-04-23T11:00:00Z</lastmod><news:news><news:publication_date>2026-04-23T11:00:00Z</news:publication_date>
        <news:title><![CDATA[What Makes Trial Design So Hard in Obesity and Oncology Right Now ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>